在一项基于人口的尸体解剖研究中,阿波利波蛋白E ε2基因与动脉阻塞的风险较低有关
Regina Silva Paradela1, Daniela Souza Farias-Itao2, Renata E P Leite2
1Division of Geriatrics, University of Sao Paulo Medical School, Brazil.
概括
携带阿波利波蛋白E (APOE) -ε2等位基因的携带者显示,心动脉阻塞和狭窄减少. 在这项尸体解剖研究中,APOE-ε4等位基因与动脉动脉样硬化风险的增加无关.
科学领域:
- 心血管科学 心血管科学
- 遗传学 遗传学 是一个
- 病理学 病理学 病理学
背景情况:
- 阿波利波蛋白E (APOE) ε4基因基因与动脉动脉样硬化风险的增加有关,而APOE-ε2可能会减少它.
- 尸体解剖研究提供了全面的动脉评估,但对于APOE等位基因关联来说很少.
- 这项研究调查了在尸检队列中APOE等位基因和直接动脉动脉样硬化测量.
研究的目的:
- 检查阿波利波蛋白E (APOE) 基因变异 (ε2, ε3, ε4) 和大脑动脉样硬化之间的关系.
- 评估与APOE等位基相关的动脉内膜介质厚度 (IMT) 和狭窄症严重程度.
- 为了确定年龄,性别或种族是否会改变APOE等位基因与动脉样硬化之间的关联.
主要方法:
- 动脉内心介质厚度 (IMT) 和狭窄是在常见的动脉 (CCA) 和内部的动脉 (ICA) 中测量.
- 使用实时聚合酶连锁反应来确定APOE基因型.
- 回归模型分析了APOE组 (ε2, ε3, ε4) 和动脉样硬化之间的关联,包括相互作用术语.
主要成果:
- APOE-ε2组表现出下动脉阻塞和较少的严重狭窄症 (≥70%).
- 携带至少一个APOE-ε4等位基因与大脑动脉样硬化无关.
- APOE等位基因与动脉IMT没有相关性,与年龄,性别或种族的相互作用并不显著.
结论:
- 携带APOE-ε2的携带者表现出较低的动脉阻塞百分比和较不严重的狭窄.
- 在这项基于人群的尸体解剖研究中,APOE-ε4等位基因与心血管动脉样硬化风险升高无关.
更多相关视频
07:51Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
Published on: January 13, 2012
20.3K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.0K
相关概念视频
01:26Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
01:30Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
01:30Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
01:26Coronary Artery Disease IV: Preventive Measures
24
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
02:23RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K